Latest news with #neonatalcare
BBC News
6 days ago
- General
- BBC News
Premature baby's care at Leeds hospital 'unacceptable'
The parents of a premature baby boy who died just hours after his birth have described the care he received in hospital as "unacceptable".Benjamin Arnold developed breathing difficulties shortly after being born just over five weeks before his due date at St James's Hospital in Leeds in "missed" opportunities to diagnose a pneumothorax, also known as a collapsed lung, and had this been treated he would likely have survived, area coroner Oliver Longstaff said at an Teaching Hospitals NHS Trust (LTHT), which runs the hospital, said it was "extremely sorry that Benjamin died whilst in our care". 'Missed opportunity' Mr Longstaff's narrative conclusion, following the inquest into Benjamin's death at Wakefield Coroner's Court last week, said the baby had "collapsed" during a procedure to help his underdeveloped lungs to breathe three hours after his to resuscitate him were ultimately unsuccessful and he was pronounced dead less than eight hours after he was Longstaff said there was a "missed opportunity to consider the possibility" of a pneumothorax early on in the process, because procedure policy "did not mandate a chest X-ray", which he said would probably have revealed it.A further opportunity was also missed when the medic performing the procedure did not discuss it with the neonatal consultant involved, the coroner added. The consultant would likely have asked if a pneumothorax had been ruled out as a cause of Benjamin's condition, the conclusion Longstaff said: "No thought was given to the pneumothorax being a potential, and potentially reversible, cause of the collapse."If they had been treated he would have, on the balance of probabilities, survived."The coroner said he was preparing a prevention of future deaths report, which would examine what lessons could be learned from the case and that would be published in due course. 'Important changes' In a statement to the BBC, Benjamin's parents said: "We are devastated by Benjamin's death."The standard of care he received was unacceptable."We urge Leeds Teaching Hospitals Trust to take the prevention of future deaths report seriously."We ask the government to urgently provide the funding for the new hospital building in Leeds. "This would allow all maternity and neonatal care to be provided from a single site and improve patient safety. This cannot wait any longer."In January, Health Secretary Wes Streeting announced the planned redevelopment of Leeds General Infirmary would not begin before 2030. At the time Professor Phil Wood, chief executive of Leeds Teaching Hospitals, said he was "extremely disappointed" by the the inquest, Dr Magnus Harrison, LTHT's medical director, said: "I am extremely sorry Benjamin died whilst in our care and I cannot imagine how difficult the last three years have been for his family."I want to reassure everyone that we have already made important changes to improve our neonatal service."These include changes to our policies to have a consultant neonatologist available on each hospital site and involving them earlier in the delivery of complex clinical procedures."While we recognise these do not undo the loss of Benjamin, we will continue to review our service and make improvements so we can deliver the best possible care for our babies and their families." Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Al Arabiya
29-05-2025
- Health
- Al Arabiya
Hospital says baby of Israeli woman killed in West Bank has died
The baby of an Israeli woman killed by a Palestinian gunman in the occupied West Bank two weeks ago has died, the hospital treating the newborn said Thursday. On May 14, Tzeela Gez was on her way from her home in the West Bank settlement of Bruchin to a Tel Aviv hospital to give birth when the gunman opened fire on the vehicle she was travelling in with her husband. Gez, 37, died of her wounds, while her baby was delivered by emergency caesarean section, the hospital that treated them said. But on Thursday, Schneider Children's Medical Center announced 'with regret that last night the baby Ravid Chaim, who was born after the terror attack in Samaria (the northern West Bank) about two weeks ago in which his mother, Tzeela Gez, of blessed memory, was murdered, has passed away.' Ravid had been in 'serious condition in the neonatal intensive care unit', where doctors had 'fought for his life', the hospital added. 'Unfortunately, despite the many efforts, the hospital was forced in recent hours to declare his death.' The Israeli military said last week that the shooter had been identified and 'eliminated' following a manhunt in the West Bank. Like all Israeli settlements in the occupied Palestinian territories, Bruchin is considered illegal under international law. 'There are no words that can console the murder of a newborn infant together with his mother,' Israeli Prime Minister Benjamin Netanyahu said. 'The heroism of the pioneering settlers in Judea and Samaria and their self-sacrifice are what will defeat all our enemies.' Israel's far-right Minister of National Security Itamar Ben-Gvir called the attack a reminder of 'the need for a decisive response against a cruel enemy who kills mothers and children as a pastime.' Denouncing the deaths, the head of the Samaria Regional Council, Yossi Dagan, called for 'construction and more construction in memory of Ravid and Tzeela.' Earlier on Thursday, Israel announced that the security cabinet had approved the creation of 22 new settlements in the West Bank.
BBC News
29-05-2025
- General
- BBC News
Level 2 baby care status reinstated at Kettering General Hospital
A neonatal unit has regained approval to care for some of the region's most premature babies, following improvements in staffing and a downgrade in September 2023, the unit at Kettering General Hospital has now been fully reapproved to operate as a Level 2 Local Neonatal Unit. This meant staff can once again care for babies born after 27 weeks of gestation, or 28 weeks for multiple births, who weigh more than 800 Hogg, University Hospitals of Northamptonshire chief nurse, said: "We are committed to ensuring our neonatal unit delivers the best possible care to babies and families in our local community and ensuring that care is tailored to their needs." The unit was temporarily downgraded to Level 1 in 2023, which meant it could only care for babies born after 32 weeks. Babies born earlier or who were very sick had to be sent to specialist Level 3 decision was made after regular safety checks and staff feedback showed the unit needed more senior doctors and extra then, the hospital has made several important improvements, including hiring two neonatal consultants, a lead nurse for governance, a data analyst, and seven additional also took part in extra training sessions, including team-based practice for emergencies like resuscitation and managing breathing problems. 'Dedicated work' Leadership at the unit has also been strengthened, and links with regional neonatal care networks have been than 70% of the nurses were fully trained to care for very premature and unwell babies, meeting national standards set by the British Association of Perinatal Hogg added: "Once again, we are able to deliver intensive care, high dependency care, and special care to babies born after 27 weeks of gestation or 28 weeks if a multiple birth."I want to take this opportunity to thank our teams for all of the dedicated work and effort that has gone into achieving the improvements that have enabled us to start delivering level 2 care once again." Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
Yahoo
27-05-2025
- Yahoo
Friends of pregnant Wichita woman killed in shooting honor her memory
WICHITA, Kan. (KSNW) — 20-year-old Naomi Oglesby was shot and killed in South Wichita early Sunday morning. She was pregnant at the time, and doctors managed to save her baby. Now her friends are speaking out about how they hope she is remembered. They say they are in shock, angry that this could happen to somebody so close to them. They find some comfort in imagining the life her child will have. They say she was only a few weeks from her due date. Naomi's daughter is getting round-the-clock attention in a neonatal intensive care unit. Naomi's close friends Tayleahna Officer and Mallory Baima both wore binkies on chains as mementos. 'It's actually the last binky she actually touched and left in my car,' Officer said. 'She had a bright, bright plan ready for the both of them. She loved her, and she was going to lover her to the fullest. No matter what.' Mallory Baima called Naomi the daughter she never had. 'I was the last person that talked to her, me and her would be on Facetime all the time,' Baima said. 'We might not have been blood … but we just had that connection, where it was that love.' Madison Lee met Naomi in school over ten years ago. She reflected on Naomi's sense of humor, and how she would want them to cope with her loss. 'Hopefully … we can move on. I don't think it's going to be easy, but if you knew Naomi, Naomi would want us to. She wouldn't want us just sitting around here crying about her. I mean she's probably laughing at us right now, she's just not that type of person.,' Lee said. Much like Naomi, Laci Dooling is also a young mom. She found herself bonding with Naomi over their shared experiences. 'It was something that I had with nobody else, I have sisters that have had babies, I have had friends that had babies. But with Naomi it was just different, ' Dooling said. 'I felt safe, I never felt judged. I could talk to about all the bad things. About the shame, the guilt and the depression I was feeling during my pregnancy.' All called for justice to be served as quickly as possible and provided a GoFundMe link established by Naomi's sister. The case is still ongoing, and one arrest was made in connection to the shooting. KSN does not name suspects until they are charged. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
23-05-2025
- Business
- Yahoo
Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche's SBX sequencing technology1, with an initial focus on critically ill newborns and their parents. Whole genome sequencing can help diagnose babies with suspected genetic disorders, such as cystic fibrosis and sickle cell disease. This project will explore how this technology could become part of routine clinical practice for newborns, as well as its use in other research applications. Basel, 23 May 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche's recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This collaboration will focus on harnessing the power of the SBX technology to transform clinical genomics and biomedical discovery. It will also aim to establish the SBX technology as a routine offering for fast, scalable sequencing for Broad Clinical Lab's research community. The first project will see Broad Clinical Labs using the SBX technology to advance research into trio-based whole genome sequencing of critically ill newborns and their biological parents. This program aims to establish a future state where whole genome sequencing becomes a routine component of clinical care in neonatal intensive care units (NICUs) —enabling precise, timely diagnoses and improved outcomes for infants with suspected genetic disorders. 'The SBX technology was designed with both clinical impact and scientific discovery in mind, and offers the next-generation of fast, scalable sequencing solutions,' said Matt Sause, CEO of Roche Diagnostics. 'Collaborating with Broad Clinical Labs, a leader in clinical genomics and omics research, accelerates our ability to deliver on that promise and support better outcomes for patients through cutting-edge genomic technology.' 'Integrating the SBX technology into clinical and translational pipelines opens exciting new possibilities,' said Niall Lennon, Chair and CSO at Broad Clinical Labs. 'Together with Roche, we're aiming to demonstrate how fast, scalable, and high-quality sequencing can support both routine clinical care and drive biomedical innovation.' The SBX technology represents a significant leap forward in next-generation sequencing, offering ultra-fast turnaround times, exceptional scalability, and cost efficiency across a range of sequencing applications. The SBX technology has been tailored to deliver high-throughput performance with a flexible workflow that will support rapid deployment in time-sensitive settings like neonatal intensive care units (NICUs) and comprehensive multi-omic discovery research. The collaboration will also explore the capabilities of the SBX technology for RNA sequencing, including both bulk and single-cell approaches. These efforts will focus on leveraging the longer reads of the SBX technology to unlock novel molecular insights and data types that could reshape how researchers understand disease mechanisms and identify new therapeutic targets. Broad Clinical Labs is a wholly owned subsidiary of the Broad Institute of MIT and Harvard. Broad Institute researchers, who have led the field in the development and application of single cell methods across a range of biomedical areas, will be the early users to leverage the new system. The collaboration between Roche and Broad Clinical Labs reflects a shared vision of a genomics-enabled healthcare system and reinforces both organizations' commitment to advancing precision medicine at scale. About Sequencing by Expansion (SBX) technologyRoche's groundbreaking next-generation sequencing technology is designed to overcome the limitations of traditional sequencing methods. As well as high accuracy, it also offers an unparalleled combination of flexibility and speed, making it a versatile tool for a wide range of genomic applications. One of the key benefits of the SBX technology is its scalability. The chemistry is coupled with an advanced, high-throughput CMOS sensor module that enables ultra-rapid, real-time base calls and analysis. This module is designed to process numerous samples simultaneously, creating a highly scalable and flexible architecture for cost-efficient sequencing across different project sizes, from small-scale studies to large projects involving thousands of samples. This versatility makes the SBX technology suitable for a variety of applications, including whole genome sequencing, whole exome sequencing, and RNA sequencing. As a result, it holds promise not only for research laboratories but also eventually for clinical settings where detailed genomic insights are crucial. With SBX technology, researchers can meet new and evolving research demands efficiently, paving the way for significant advances in our understanding of genetics and disease, ultimately contributing to better healthcare outcomes. The SBX chemistry was invented by Mark Kokoris and Robert McRuer who co-founded Stratos Genomics. Stratos Genomics was acquired by Roche in 2020. To find out more about Roche's novel SBX technology, click here. About Broad Clinical LabsBroad Clinical Laboratories was founded in 2013 as a subsidiary of Broad Institute, Inc. to accelerate the world toward a better understanding, diagnosis, and treatment of disease by pursuing projects, developing products, and driving adoption of cutting edge -omics technologies and novel molecular assays. Broad Clinical Labs is a leader in human whole genome sequencing, having sequenced over 750,000 genomes in service of its mission to accelerate the understanding and diagnosis of human disease. For more information, please visit About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. For over 125 years, sustainability has been an integral part of Roche's business. As a science-driven company, our greatest contribution to society is developing innovative medicines and diagnostics that help people live healthier lives. Roche is committed to the Science Based Targets initiative and the Sustainable Markets Initiative to achieve net zero by 2045. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit All trademarks used or mentioned in this release are protected by The SBX technology is in development and not commercially available. The content of this material reflects current study results or design goals. Roche Global Media RelationsPhone: +41 61 688 8888 / e-mail: Hans Trees, PhDPhone: +41 79 407 72 58 Sileia UrechPhone: +41 79 935 81 48 Nathalie AltermattPhone: +41 79 771 05 25 Lorena CorfasPhone: +41 79 568 24 95 Simon GoldsboroughPhone: +44 797 32 72 915 Karsten KleinePhone: +41 79 461 86 83 Nina MählitzPhone: +41 79 327 54 74 Kirti PandeyPhone: +49 172 6367262 Yvette PetillonPhone: +41 79 961 92 50 Dr Rebekka SchnellPhone: +41 79 205 27 03 Roche Investor Relations Dr Bruno EschliPhone: +41 61 68-75284e-mail: Dr Sabine BorngräberPhone: +41 61 68-88027e-mail: Dr Birgit MasjostPhone: +41 61 68-84814e-mail: Investor Relations North America Loren KalmPhone: +1 650 225 3217e-mail: Attachment 23052025_SBX Broad Clinical Labs_enError while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
